Vinstin Injection 2 mg/2 ml contains Vincristine Sulfate, a chemotherapeutic agent belonging to the class of vinca alkaloids. It is used for the treatment of various types of cancer, including acute lymphoblastic leukemia (ALL), Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, multiple myeloma, and certain solid tumors.
Vincristine works by inhibiting cell division, preventing the growth and spread of cancer cells. Vinstin Injection is administered intravenously under strict medical supervision as part of combination chemotherapy regimens. Its potent action makes it an essential therapy in both pediatric and adult oncology for curative and palliative purposes.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Vincristine Sulfate 2 mg per 2 ml vial
Vincristine, the active ingredient in Vinstin Injection, works by:
Inhibition of microtubule formation – Vincristine binds to tubulin in cancer cells, preventing the formation of microtubules necessary for mitosis.
Cell cycle arrest – Disrupts mitotic spindle formation, halting cell division at metaphase.
Induction of apoptosis – Triggers programmed cell death in rapidly dividing cancer cells.
Selective action on proliferating cells – Targets malignant cells more effectively than normal cells, though some healthy rapidly dividing cells can also be affected.
Through this mechanism, Vincristine reduces tumor growth and helps achieve remission in hematologic and solid malignancies.
Vinstin Injection 2 mg/2 ml is indicated for:
Acute lymphoblastic leukemia (ALL) – In children and adults as part of combination chemotherapy
Hodgkin’s lymphoma – For remission induction and maintenance therapy
Non-Hodgkin’s lymphoma – As part of multi-drug regimens
Multiple myeloma – In combination with other chemotherapeutic agents
Other solid tumors – Including neuroblastoma, Wilms tumor, and sarcomas under specialist guidance
Administration: Intravenous injection or infusion only; never administer intrathecally, as this can cause fatal neurotoxicity
Typical adult dose: 1.4 mg/m² body surface area once weekly (maximum 2 mg per dose)
Pediatric dosing: Adjusted according to body surface area and treatment protocol
Monitoring: Regular assessment of blood counts, liver function, and neurological status during treatment
Combination therapy: Usually administered with other chemotherapy drugs according to standardized regimens
Potent anticancer activity against a wide range of hematologic and solid tumors
Effective in combination chemotherapy regimens for improved remission rates
Can be used in both induction and maintenance therapy
Helps reduce tumor burden and achieve disease control in aggressive cancers
Administer only under strict oncological supervision
Monitor for myelosuppression, peripheral neuropathy, and gastrointestinal disturbances
Use caution in patients with liver impairment as dose adjustment may be necessary
Pregnancy and breastfeeding: Contraindicated due to potential fetal toxicity
Avoid inadvertent intrathecal administration, which is life-threatening
Inform your physician of all concurrent medications to avoid interactions, particularly other neurotoxic or myelosuppressive drugs
Common side effects:
Fatigue and hair loss
Constipation or abdominal discomfort
Peripheral neuropathy (numbness, tingling, or weakness in hands and feet)
Mild nausea or vomiting
Serious side effects:
Severe myelosuppression (low blood counts)
Neurotoxicity leading to paralysis or severe neuropathy
Liver toxicity in rare cases
Severe allergic reactions
Immediate medical attention is required for unusual bleeding, persistent infections, severe neuropathy, or allergic reactions.
Store between 2–8°C; do not freeze
Protect from light and moisture
Keep vials in original packaging until use
Keep out of reach of children
Vinstin Injection 2 mg/2 ml offers powerful chemotherapy treatment, effectively targeting rapidly dividing cancer cells and forming an essential component of combination therapy for leukemia, lymphoma, and other malignancies.
Login Or Registerto submit your questions to seller
No none asked to seller yet